Skip to content
ClearDaily

Zimbabwe Turns Down ‘Unbalanced’ US Health Aid Package Because of Information Apprehensions

Health aid image
The proposed American financial assistance was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

The nation of Zimbabwe has rejected a significant American healthcare agreement valued at 367 million US dollars (£272m) over five years over Washington's demand for sensitive data.

This move was revealed following a government memo from December was disclosed, indicating that President Emmerson Mnangagwa believed the agreement was "skewed".

A government spokesperson has since clarified that the United States was requesting health data for research and commercial gain but was unwilling to share the resulting advantages from future treatments.

"We must now begin the difficult and regrettable task of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy noted the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has appealed for continued talks to secure a deal acceptable to both sides so the nation's vital HIV programme can continue.

Broader Implications

This rejection follows a similar situation in neighbouring Kenya, where a high court blocked a similar deal with the US following legal challenges were filed about the safety of Kenyans' health data.

Since returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).

USAID had overseen assistance for the US government, but Trump argued its expenditure was "wasteful" and his government was seeking government-to-government deals to boost openness and accountability.

According to statements, Sixteen African countries have to date signed similar agreements, representing more than $18.3bn of fresh investment.

Specifics of the Declined Agreement

This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this cooperation would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy through US-supported programmes," the Ambassador added.

However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".

"Zimbabwe was being asked to provide its biological resources and data for a long time, with no corresponding promise of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that shared data," his statement read.

"Put simply, our nation would provide the basic resources for scientific discovery without any certainty that the final treatments would be accessible to our population should a new disease outbreak emerge."

Sovereignty and International Frameworks

He also noted that the US's withdrawal from the global health body and its pursuit of bilateral deals were upending systems already established through the international organization.

The spokesperson cited its Pathogen Access and Benefit Sharing framework created to deal with potential pandemics.

"This mechanism is designed to guarantee that when a nation provides its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the capability to create them."

These objections regarding the US deal "must not be interpreted as hostility towards the US," he added.

"We welcome continued dialogue with our American counterparts on how future collaboration could be designed in a way that honours the sovereignty and dignity of both nations."

Health Experts Response

Medical experts said it acknowledged the official position, but urged that negotiations should continue given that much of the country's HIV programmes relied on external financing.

"Where technical issues exist, such as those involving information security or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," it commented.

This impasse emphasises the ongoing debate between accepting crucial foreign assistance and protecting a country's data in an ever more interconnected world.

The writer

Shannon Hall

A seasoned journalist with over a decade of experience in digital media, specializing in tech and culture reporting.

ClearDaily

Type to search articles.